CD19 Redirected Autologous T Cells for Hodgkin Lymphoma
Clinical trial NCT02277522 · TERMINATED
Trial details
- NCT number
- NCT02277522
- Sponsor
- University of Pennsylvania
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2016-11-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.